About: Tocilizumab plus glucocorticoids in severe and critically COVID-19 patients. A single center experience

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Tocilizumab plus glucocorticoids in severe and critically COVID-19 patients. A single center experience Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : wasabi.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
title	Tocilizumab plus glucocorticoids in severe and critically COVID-19 patients. A single center experience
Creator	Ruiz, Pablo Jiménez-Brítez, Gustavo Soler, Xavier
source	Elsevier; Medline; PMC
abstract	covid:9a7e58164cf8e033005b26a22c6b0e27aa6171b7#abstract
has issue date	2020-07-09(xsd:dateTime)
bibo:doi	10.1016/j.medcli.2020.07.001
bibo:pmid	32718713
has license	els-covid
sha1sum (hex)	9a7e58164cf8e033005b26a22c6b0e27aa6171b7
schema:url	https://doi.org/10.1016/j.medcli.2020.07.001
resource representing a document's title	Tocilizumab plus glucocorticoids in severe and critically COVID-19 patients. A single center experience
has PubMed Central identifier	PMC7346781
has PubMed identifier	32718713
schema:publication	Med Clin (Barc)
resource representing a document's body	covid:9a7e58164cf8e033005b26a22c6b0e27aa6171b7#body_text
is schema:about of	named entity 'glucocorticoids' named entity 'critically' named entity 'Tocilizumab' named entity 'COVID-19' named entity 'glucocorticoids' named entity 'secondary infection' named entity 'COVID' named entity 'FiO2' named entity 'tocilizumab' named entity 'glucocorticoids' named entity 'tocilizumab' named entity 'COVID' named entity 'clinical outcomes' named entity 'humanized monoclonal antibody' named entity 'pneumonia' named entity 'COVID-19' named entity 'IL-6 receptor' named entity 'lymphocytes' named entity 'Italy' named entity 'Corticosteroids' named entity 'clinical outcomes' named entity 'superinfection' named entity 'dimer' named entity 'D-dimer' named entity 'IL-6' named entity 'observational studies' named entity 'COVID' named entity 'recombinant' named entity 'proinflammatory cytokines' named entity 'anti-inflammatory' named entity 'CPR' named entity 'interleukin 6' named entity 'tocilizumab' named entity 'COVID' named entity 'COVID-19' named entity 'COVID-19' named entity 'fever' named entity 'fever' named entity 'critically ill patients' named entity 'oxygen' named entity 'Tocilizumab' named entity 'Intensive Care Unit' named entity 'COVID' named entity 'ICU' named entity 'Barcelona' named entity 'pharmacological' named entity 'invasive mechanical ventilation' named entity 'methylprednisolone' named entity '3, 4' named entity 'oxigen' named entity 'CPR' named entity 'controlled trials' named entity 'Methylprednisolone' named entity 'observational study' named entity 'invasive ventilation' named entity 'anti-inflammatory' named entity 'cytokine storms' named entity 'China' named entity 'COVID' named entity 'cytokines' named entity 'critically ill patients' named entity 'Spain' named entity 'glucocorticoids' named entity 'single center' named entity 'COVID-19' named entity 'Journal' named entity 'patients' named entity 'EXPERIENCE' named entity 'Tocilizumab' named entity 'GLUCOCORTICOIDS' named entity 'CENTER' named entity 'TOCILIZUMAB' named entity 'PATIENTS' named entity 'JOURNAL ' named entity 'COVID-19' named entity 'PRE' named entity 'PROOF' named entity 'SEVERE' named entity 'SINGLE'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software